GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:DRNA
Delisted

Dicerna Pharmaceuticals Stock Price (Quote)

$38.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.22 $38.22 Friday, 27th May 2022 DRNA stock ended at $38.22. During the day the stock fluctuated 0% from a day low at $38.22 to a day high of $38.22.
90 days $38.22 $38.22
52 weeks $19.06 $40.14

Historical Dicerna Pharmaceuticals prices

Date Open High Low Close Volume
2019-08-19 $14.62 $14.62 $14.17 $14.33 532 187
2019-08-16 $14.77 $15.03 $14.20 $14.37 504 973
2019-08-15 $14.19 $14.68 $14.08 $14.59 365 961
2019-08-14 $13.98 $14.22 $13.82 $14.05 514 174
2019-08-13 $14.10 $14.61 $13.86 $14.47 275 654
2019-08-12 $13.53 $14.34 $13.31 $14.12 352 211
2019-08-09 $13.97 $14.74 $13.52 $13.59 509 492
2019-08-08 $13.45 $14.00 $13.43 $13.78 307 432
2019-08-07 $12.98 $13.49 $12.84 $13.29 778 855
2019-08-06 $12.90 $13.13 $12.69 $13.12 344 204
2019-08-05 $12.76 $13.05 $12.53 $12.71 265 797
2019-08-02 $13.40 $13.63 $12.76 $13.01 376 258
2019-08-01 $13.63 $13.92 $13.30 $13.46 378 271
2019-07-31 $14.20 $14.37 $13.54 $13.63 335 167
2019-07-30 $13.83 $14.25 $13.75 $14.20 484 240
2019-07-29 $14.52 $14.65 $13.53 $13.92 452 955
2019-07-26 $14.54 $14.78 $14.39 $14.50 421 354
2019-07-25 $15.17 $15.35 $14.47 $14.49 311 300
2019-07-24 $15.70 $15.82 $15.04 $15.15 307 183
2019-07-23 $15.58 $15.81 $15.33 $15.74 284 217
2019-07-22 $15.10 $15.49 $14.94 $15.47 182 311
2019-07-19 $15.75 $15.80 $14.98 $15.10 248 963
2019-07-18 $14.96 $16.02 $14.96 $15.78 376 228
2019-07-17 $14.34 $15.01 $14.24 $14.97 325 485
2019-07-16 $14.20 $14.46 $14.14 $14.33 413 684
Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT